Amgen Inc. buy Royal Bank of Canada
Start price
14.06.24
/
50%
€278.00
Target price
14.06.25
€310.92
Performance (%)
-7.41%
End price
15.06.25
€257.40
Summary
This prediction ended on 15.06.25 with a price of €257.40. With a performance of -7.41%, the BUY prediction by Royal_Bank_of_Canada finished with a loss. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.81 was paid as dividends for this prediction. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -0.244% | -0.244% | 7.554% |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $328.00 to $332.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten